Practice areas

Capital markets; M&A; Private equity, venture capital & funds; Cross-border investment

Introduction

With more than 30 years’ experience in the areas of international commercial law and corporate compliance, Lin Zhong has advised many influential cases in the areas of corporate, M&A, foreign investment, IP, dispute resolution, and antitrust. In 2015, China Law & Practice rated Lin as the leading Asia lawyer. In 2019, The Legal 500 Asia Pacific rated him as recommended lawyer in the area of corporate/M&A. He was listed on the A-List in 2017-2020 by China Business Law Journal.

Lin was the deputy director of the antitrust law committee of the All China Lawyers Association as well as the Competition Law Society of the Shanghai Law Society. He was the head of the anti-monopoly professional committee of the Shanghai Bar Association. In 2011, he was appointed as a part-time professor at Xiamen University Law School. Currently, he is the vice chairman of the Xiamen University Shanghai Alumni Association, chairman of the Xiamen University Yangtze River Delta Alumni Equity Investment Association, and vice chairman of China International Investment Arbitration Forum.

In 2021, Lin founded Leadvisor Law Firm, consisting of professional lawyers with rich experience, providing advice with a rigorous attitude and outstanding professional ability. The team successfully assisted Advent International, one of the world’s largest and most experienced private equity funds, to complete the acquisition of the controlling interest of GS Capsule, assisted VASEN to complete its equity acquisition of Fastflow Group, and assisted Carecapital to complete its strategic investment in Hainan Dental Hospital.

Lin also plays an active role in social activities. He took the lead in establishing the Xiamen University Yangtze River Delta Alumni Equity Investment Association, devoted to the promotion of alumni communication. In the field of medical health, Lin initiated the establishment of the Mednovation Club. Mednovation is a leading medical innovation platform with international vision, which aims to bridge overseas medical innovation, empower local device ecology, and contribute to national science and technology innovation, helping overseas medical device innovation projects to land and develop in China. These platforms will form an ecosystem with Leadvisor Law, help with the promotion of legal services and also benefit participants from these industries.

Back to China A-List 2022